Exclusive vs Non-Exclusive Patent License: Who Earns More

Exclusive vs non-exclusive patent license is usually explained from the licensee's chair. Tech-transfer offices tell companies what they get: exclusivity, a head start, something investors will fund. That is useful if you are buying. If you own the patent, the question is different. What do you give up, what do you get paid for it, and what happens when the one licensee you picked does nothing?

This is the licensor's ledger. Definitions first, then what the deal data actually shows about the exclusivity premium, then the enforcement rights that change hands quietly in the US and Germany, a German renewal-fee rule almost nobody mentions, and the clauses that make an exclusive grant safe to sign.

The short answer

An exclusive licence gives one licensee the right to use the patent within a defined scope, and you promise not to license anyone else there. A non-exclusive licence lets you sign the same rights with as many licensees as you like.

Exclusivity costs the licensee more. NASA's licensing team puts it plainly: upfront fees, running royalties and annual minimum royalties are generally higher for exclusive licences, and the exclusive licensee is often responsible for the patent maintenance fees too.

But a higher price per deal is not the same as more money. WIPO's licensing manual notes that non-exclusive licensing is the preferred option of most licensors, because spreading the technology across several licensees means the owner does not depend on one company's success. The same manual explains why exclusivity still wins in many deals: early-stage technology that needs heavy further investment rarely finds a licensee willing to take that risk without it.

So the honest rule is this. Exclusive earns the owner more when the licensee must invest heavily before any product exists, and when the contract forces that licensee to perform. Non-exclusive earns more when the technology is ready, broadly useful, and several companies would pay to use it without needing to block each other.

Three grants, not two: exclusive, sole and non-exclusive

Most pages treat this as a binary. In practice there are three grants, and the words get used loosely.

Exclusive

Simon Fraser University's licensing office defines it cleanly: under an exclusive licence the licensee has the sole right to use the IP within the defined scope, and unless the agreement says otherwise, that excludes even the owner. It is the most restrictive arrangement from the licensor's side.

Sole

A sole licence sits in the middle. The licensee is the only outside party allowed in, but the owner keeps the right to use the invention itself. WIPO warns that the distinction blurs and that "exclusive" is sometimes written where a sole licence is meant. If you plan to keep manufacturing, say so in the grant clause.

Non-exclusive

The owner can grant the same rights to anyone and keep using the patent. It is the least restrictive option for the licensor, and the licensee gets no protection from competitors who sign the same terms.

The scope matters as much as the label. Exclusivity is granted within a territory and a field of use, and NASA, for example, may license the same technology to others outside the exclusive field of use. One patent can therefore carry an exclusive licence in medical devices, another in automotive, and non-exclusive licences everywhere else.

What exclusivity is worth in the data

Every source agrees that exclusivity commands a premium. Very few say how large it is, and the raw numbers can mislead you.

Why the raw averages look backwards

The Licensing Executives Society (USA and Canada) runs a recurring high-tech royalty survey. In its 2021 round, 43% of deals were exclusive and 53% non-exclusive, and the median royalty rate across all four surveys since 2011 stayed at 5%. Its regression analysis found that exclusive licences carry a significant royalty premium, alongside technologies in a fully developed stage and deals that include know-how.

Yet when the same survey team first tabulated simple averages, the pattern looked inverted. Jack Lu and Manta Zhang describe a seemingly counterintuitive royalty rate behaviour across exclusive and non-exclusive deals and trace it to who the licensors were. Universities and other institutions grant many exclusive licences at modest rates, which drags the exclusive average down. Compare like with like and the premium reappears.

What the controlled studies find

Two academic studies make the same point with larger samples.

Kankanhalli and Kwan studied licensing contracts disclosed in public company filings. Around 60% were exclusive, and the unconditional link between exclusivity and royalty rate was weak. The premium became robust once they accounted for competition: exclusivity is worth more when the licensee's product market is crowded, because blocking rivals is the thing being bought. They also found that individuals, nonprofits and universities command significantly lower rates, which is exactly the effect that distorts the raw averages.

A 2023 PLOS One study of 239 academic and 916 corporate biotechnology licences measured the gap directly. Non-exclusive licences had a median effective royalty rate 1.6 percentage points lower than exclusive licences, a statistically significant difference.

What this means for an owner: exclusivity is a price you can charge for, but only when the licensee faces real competition and you negotiate like a company rather than like a tech-transfer office. If you want the benchmarks by field, start with our breakdown of average patent licensing royalty rates. These figures describe past deals; they do not predict what any specific patent will earn.

Who can sue: the right that changes hands quietly

The royalty rate gets negotiated. The right to enforce the patent often gets decided by accident.

United States

A non-exclusive licensee cannot sue infringers; it holds a permission, not a right to exclude. An exclusive licensee may be able to, depending on what was transferred. In University of South Florida Research Foundation v. FujiFilm, the Federal Circuit called the licensor's retained right to sue the most important factor in deciding whether an exclusive licence transfers all substantial rights, and held that a licence silent on the point reserves it to the owner. Where the licensee falls short of all substantial rights, it cannot sue without joining the patent owner.

For the owner, this cuts both ways. Grant too much and the licensee controls litigation over your patent. Grant too little and your exclusive licensee cannot act alone when a competitor copies the product it paid to protect.

Germany and the UPC

The German Patent Act states that patent rights can be the subject of exclusive or non-exclusive licences, in full or in part (Section 15(2)), and that a later transfer or licence does not affect licences previously granted (Section 15(3)). An exclusive licensee can claim damages in its own name. The owner does not lose its own claims either: the Federal Court of Justice held in Cinch-Stecker (X ZR 86/10) that an owner who granted an exclusive licence keeps its own infringement claims if it still participates economically, for example through running royalties.

At the Unified Patent Court, an exclusive licensee may bring an action after giving the proprietor prior notice, unless the licence limits that right. If you hold a European patent with UPC effect and do not want a licensee litigating on its own timetable, the licence has to say so.

This is a description of how the rules work, not legal advice. The point is practical: the enforcement clause is part of the price.

The German renewal-fee trade-off

Here is a rule the ranking pages skip. Under Section 23 of the German Patent Act, an owner who declares to the DPMA that it will let anyone use the invention for equitable remuneration (a licence of right) pays only half the annual renewal fees from then on. The DPMA's fee schedule confirms that annual fees are reduced by half with such a declaration.

The catch: the declaration is inadmissible while an exclusive licence is recorded in the register under Section 30(4), and an exclusive licence cannot be recorded once the declaration is made. For a German patent, choosing exclusivity can mean giving up a permanent 50% fee discount.

That matters most for patents still waiting for a licensee. If the asset is costing you money every year, the trade-off sits squarely inside the wider question of when patent renewal fees are worth paying at all.

Which earns the owner more: a decision table

Exclusive deals also carry more components than a royalty rate. The University of Kentucky's research foundation describes its typical exclusive licence as including an issue fee and/or equity, minimum annual royalties, a share of sublicensing income, field-of-use limits and reimbursement of patent costs. If your exclusive term sheet contains only a rate, you are leaving most of the levers on the table.

If neither licence type fits because you would rather not manage licensees at all, the comparison to make is whether to license or sell your patent.

Clauses that make exclusivity safe to grant

The real risk of an exclusive licence is not a low rate. It is a licensee that signs, shelves the technology, and blocks everyone else. Patent lawyers James and Wells describe that risk and the fix: impose definite performance obligations, and if they are missed, terminate or convert the licence to non-exclusive. They suggest a trigger such as the licensee paying only the minimum royalty in two consecutive years.

The protective set, in order of importance:

1. Minimum annual royalty. Turns "best efforts" into a number. WIPO recommends it for any exclusive or sole grant.
2. Diligence milestones. Dated commercial steps: prototype, regulatory filing, first sale.
3. Conversion right. Missed minimums or milestones convert exclusive to non-exclusive at your option, so you can license others without a lawsuit.
4. Narrow scope. Exclusive only in the field and territory the licensee can actually serve. Keep the rest open for non-exclusive deals.
5. Sublicensing share. If the licensee may sublicense, you take a share of that income.
6. Enforcement terms. Who may sue, who controls the case, who pays, how damages split. Silence defaults to rules you may not like.
7. Upfront fee. James and Wells cite survey work finding that around 60% of licences include an upfront payment. It funds your prosecution costs and tests the licensee's commitment on day one.

For how these terms show up in practice with institutional licensors, see our walkthrough of a university patent licensing agreement, and for the full clause map, what a patent licensing agreement contains. Where two companies each hold rights the other needs, the answer may be neither licence type alone but patent cross licensing.

How EX-IX structures it

We do not treat exclusivity as a yes or no. EX-IX sells and licenses the rights it holds carved by industry, territory or field of use, with title kept whole. One family can carry an exclusive grant to the licensee best placed in one field and non-exclusive grants elsewhere, which is how a patent becomes several transactions instead of one.

Before rights reach a licensee or buyer, they pass a digital-twin validation gate that reconstructs the claims and tests detectability. That matters for exclusivity in particular: a licensee paying a premium to block competitors wants evidence that infringement can actually be detected.

The caveat, stated plainly: licensing income is never certain, whichever structure you choose. Many licences pay only their minimums, and many patents never find a licensee at all.

FAQ

Can a patent owner use the invention under an exclusive license?

Not under a true exclusive licence unless the agreement reserves that right. If you want to keep using the invention yourself while blocking other licensees, grant a sole licence, or write the reservation into the exclusive grant explicitly.

Can a non-exclusive license be converted to exclusive later?

Only if nobody else already holds a licence in that scope. Under German law earlier licences survive later grants, so a new exclusive licensee takes the field subject to them. The reverse, converting exclusive to non-exclusive when the licensee underperforms, is a standard protective clause.

Does an exclusive licence have to be registered in Germany?

No, recording at the DPMA under Section 30(4) is optional and requires both parties' consent. Recording it does block the Section 23 licence-of-right declaration and its renewal-fee reduction for as long as the entry stands.

What happens to existing licences if the patent is sold?

In Germany, a transfer does not affect licences already granted, so the buyer takes the patent with them. In practice, buyers price existing licences in: an exclusive licence limits what a buyer can do with the asset, while royalty-paying non-exclusive licences can make it easier to value.